1
|
Prevalence of Toxoplasma gondii and Potentially Zoonotic Helminths in Wild Boars (Sus scrofa) Hunted in Central Italy. MACEDONIAN VETERINARY REVIEW 2018. [DOI: 10.2478/macvetrev-2018-0012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
Abstract
Our aim was to evaluate the risk of human toxoplasmosis via meat consumption from wild boars by estimating the seroprevalence of Toxoplasma gondii in animals hunted in central Italy. Using a modified agglutination test, 213 sera from wild boars were examined for anti-Toxoplasma IgG antibodies. Diaphragm samples (n=65) from seropositive and seronegative animals were tested by nested-PCR to detect T. gondii DNA. Toxoplasma DNA from diaphragms was genotyped by PCR-RFLP using 12 genetic markers. Moreover, the aim of the study was also to identify helminth infections of wild boars in the selected area and to evaluate their hazard for humans. Examination of sera revealed a seroprevalence of 12.2%. Only one T. gondii strain could be genotyped from a seropositive animal and PCR-RFLP revealed that it belonged to type II. Analysis of 50 samples of faeces and 32 small intestines revealed that 78% and 15.6% of the samples harboured parasites, respectively, with the occurrence of parasites potentially dangerous for humans. These latter included Ascaris suum, Macracanthorhynchus hirudinaceus, Trichuris suis, and Metastrongylus spp. A significant association was found between coprological positivity and male sex. These results indicate that T. gondii infection may be present in wild boar tissues and consumption of undercooked or raw wild boar meat may expose humans to risk of toxoplasmosis in the study area. Furthermore, the study highlights that wild boars are hosts of helminths of veterinary and medical importance transmissible to pigs and humans.
Collapse
|
2
|
Rostami A, Riahi SM, Fakhri Y, Saber V, Hanifehpour H, Valizadeh S, Gholizadeh M, Pouya RH, Gamble HR. The global seroprevalence of Toxoplasma gondii among wild boars: A systematic review and meta-analysis. Vet Parasitol 2017; 244:12-20. [PMID: 28917302 DOI: 10.1016/j.vetpar.2017.07.013] [Citation(s) in RCA: 85] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Revised: 07/17/2017] [Accepted: 07/18/2017] [Indexed: 10/19/2022]
Abstract
This systematic review and meta-analysis study was performed to evaluate the worldwide seroprevalence of Toxoplasma gondii among wild boar. We searched PubMed, Science Direct, Web of Science, Cochrane, Scopus, EBSCOhost and Google Scholar databases for studies reporting T. gondii seroprevalence in wild boars between January 1995 and March 2017. Inclusion and exclusion criteria were applied. We estimated the pooled seroprevalence of T. gondii in wild boars using a random-effects model, and evaluated overall seroprevalence in different geographical areas. A total of 43 articles that included 16788 wild boar from 23 countries fulfilled our eligibility criteria. Of these, 4759 wild boar had been defined T. gondii seropositive and we estimated the pooled worldwide seroprevalence of toxoplasmosis in wild boars to be 23% (95% CI: 19-27%). The pooled seroprevalence in North America (32%, 20-45%; odds ratio [OR] 2.09) and Europe (26%, 21-30%; OR 1.72), was higher than Asia (13%, 5-23%). The lowest seroprevalence was estimated in South America (5%, 3-8%). An increased seropositivity was observed with elevation in geographical latitude. In subgroup analyses, the pooled seroprevalence of T. gondii was higher in wild boar older than 12 months of age (28%, 22-35%; OR 1.57) compared to those up to 12 months of age (20%, 16-25%). Our findings suggest that wild boar have an important role in human infection and the epidemiological cycle of T. gondii infection.
Collapse
Affiliation(s)
- Ali Rostami
- Infectious Diseases and Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iran; Department of Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
| | - Seyed Mohammad Riahi
- Faculty of Health, Birjand University of Medical Sciences, Birjand, Iran; Department of Epidemiology, School of Public health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
| | - Yadollah Fakhri
- Student Research Committee, Department of Environmental Health Engineering, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Vafa Saber
- Infectious Diseases and Tropical Medicine Research Center, Babol University of Medical Sciences, Babol, Iran
| | - Hooman Hanifehpour
- Department of Biological Control and Vaccine, FDA (Food and Drug Administration), Tehran, Iran
| | - Soghra Valizadeh
- Department of Food Hygiene and Quality Control, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
| | - Majid Gholizadeh
- Department of Microbiology, Khazar University, Mahmood Abad, Iran
| | | | - H Ray Gamble
- National Academy of Sciences, 500 5th Street N.W., Washington, D.C. 20001, USA
| |
Collapse
|